Cargando…
Fresh from the biotech pipeline: too much, too fast?
2021 witnessed regulators’ continued push to accelerate approvals and adjust to COVID-19, but has the pendulum swung too far in drug makers’ favor?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802986/ https://www.ncbi.nlm.nih.gov/pubmed/35102293 http://dx.doi.org/10.1038/s41587-022-01208-2 |
| _version_ | 1784642782039638016 |
|---|---|
| author | Senior, Melanie |
| author_facet | Senior, Melanie |
| author_sort | Senior, Melanie |
| collection | PubMed |
| description | 2021 witnessed regulators’ continued push to accelerate approvals and adjust to COVID-19, but has the pendulum swung too far in drug makers’ favor? |
| format | Online Article Text |
| id | pubmed-8802986 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88029862022-02-01 Fresh from the biotech pipeline: too much, too fast? Senior, Melanie Nat Biotechnol News Feature 2021 witnessed regulators’ continued push to accelerate approvals and adjust to COVID-19, but has the pendulum swung too far in drug makers’ favor? Nature Publishing Group US 2022-01-31 2022 /pmc/articles/PMC8802986/ /pubmed/35102293 http://dx.doi.org/10.1038/s41587-022-01208-2 Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | News Feature Senior, Melanie Fresh from the biotech pipeline: too much, too fast? |
| title | Fresh from the biotech pipeline: too much, too fast? |
| title_full | Fresh from the biotech pipeline: too much, too fast? |
| title_fullStr | Fresh from the biotech pipeline: too much, too fast? |
| title_full_unstemmed | Fresh from the biotech pipeline: too much, too fast? |
| title_short | Fresh from the biotech pipeline: too much, too fast? |
| title_sort | fresh from the biotech pipeline: too much, too fast? |
| topic | News Feature |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802986/ https://www.ncbi.nlm.nih.gov/pubmed/35102293 http://dx.doi.org/10.1038/s41587-022-01208-2 |
| work_keys_str_mv | AT seniormelanie freshfromthebiotechpipelinetoomuchtoofast |